Journals / Nöropsikiyatri Arşivi / 2019 / Cilt: 56 - Sayı: 1

Olanzapine Associated Acute Peripheral Edema and Pericardial Effusion: A Case Report

Olanzapin ile İlişkili Akut Periferik Ödem ve Perikardiyal Efüzyon: Bir Olgu Sunumu

Pages
79–81
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Although very rarely encountered,clinicians should be aware of these possible side-effects.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Olanzapine is a potent atypical antipsychotic drug used for the treatmentof schizophrenia and bipolar disorder with approved efficiency.Olanzapine is superior to the typical antipsychotic drugs with lowincidence of extrapyramidal side effects, especially tardive dyskinesia.
📊
Key Findings & Data:Themost common side effects associated with olanzapine are constipation,dyspepsia, weight gain, somnolence, asthenia, dry mouth and dizziness.Peripheral edema associated with olanzapine is rarely reported andas far as we know there is no report in the literature about peripheraledema concomitant with pericardial effusion related to olanzapine.
💡
Conclusion & Impact:Although very rarely encountered,clinicians should be aware of these possible side-effects.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Olanzapine is a potent atypical antipsychotic drug used for the treatmentof schizophrenia and bipolar disorder with approved efficiency.Olanzapine is superior to the typical antipsychotic drugs with lowincidence of extrapyramidal side effects, especially tardive dyskinesia. Themost common side effects associated with olanzapine are constipation,dyspepsia, weight gain, somnolence, asthenia, dry mouth and dizziness.Peripheral edema associated with olanzapine is rarely reported andas far as we know there is no report in the literature about peripheraledema concomitant with pericardial effusion related to olanzapine. Themechanism of these side effects associated with olanzapine is still unclearand there are different hypotheses in the literature. Herein we report thefirst case that developed both peripheral edema and pericardial effusionafter olanzapine administration. Although very rarely encountered,clinicians should be aware of these possible side-effects.

Özet

Olanzapin, şizofreni ve bipolar bozukluk tedavisinde etkinliği onaylanmış olan bir atipik antipsikotiktir. Tipik antipsikotiklere üstünlüğü ekstrapiramidal yan etkiler ve ağır bir yan etki olan tardif diskineziye daha az neden olmasıdır. Olanzapinin en sık görülen yan etkileri kabızlık, dispepsi, kilo artışı, uyku hali, asteni, ağız kuruluğu ve baş dönmesi olarak sayılabilir. Nadir olarak olanzapin kullanımı ile ilişkili periferik ödem vakaları bildirilmektedir. Bildiğimiz kadarıyla, literatürde periferik ödem ile birlikte perikardiyal efüzyon görülen vaka yoktur. Olanzapin kullanımı ile gelişen bu yan etkilerin mekanizması ile ilgili bilgiler halen net olmayıp literatürde farklı hipotezler mevcuttur. Bu yazıda, olanzapin kullanımına bağlı periferik ödem ve perikardiyal efüzyon gelişen literatürdeki ilk olgu sunulmuştur. Klinisyenler, diğer yan etkilere oranla çok daha az görülen bu yan etkileri de göz önünde bulundurmalıdırlar.

🔖

Cite This Article

BULUT, Ü., ARSLAN, M., NAKİ, D. D. (2022). Olanzapine Associated Acute Peripheral Edema and Pericardial Effusion: A Case Report. Nöropsikiyatri Arşivi, Cilt: 56 - Sayı: 1, 79–81. https://ajindex.com/articles/584668

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Stahl SM. Antipsychotic agents. Essential Psychopharmacology, 4th ed. Cambridge: Cambridge University Press; 2015. pp.129–236
  2. Longo DL, Kasper DL, Jameson JL, Fauci AS, Hauser SL, Lascalzo J, editors. Edema. Harrison’s Principles of Internal Medicine, 18th ed. New York: McGraw-Hill; 2012. pp.797–807
  3. Umar MU, Abdullahi AT. Self-limiting Atypical Antipsychotics-induced Edema: Clinical Cases and Systematic Review. Indian J Psychol Med 2016;38:182–188. [CrossRef] 4. Vakamudi S, Ho N, Cremer PC. Pericardial Effusions: Causes, Diagnosis, and Management. Prog Cardiovasc Dis 2017;59:380–388. [CrossRef] 5. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239–245. [CrossRef] 6. Ng B, Postlethwaite A, Rollnik J. Peripheral oedema in patients taking olanzapine. Int Clin Psychopharmacol 2003;18:57–59. [CrossRef] 7. Honma M, Minami-Hori M, Tsuji H, Komatsu S, Iizuka H. Olanzapineinduced limb edema simulating episodic angioedema with eosinophilia. J Dermatol 2012;39:1105–1106. [CrossRef] 8. Yaluğ I, Tufan AE, Özten E, Alemdar M, Cerit C. Bilateral pedal edema associated with olanzapin use in manic episode of bipolar disorder: report of two cases. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:1541–1542. [CrossRef] 9. Yağcıoğlu EA, Ertuğrul A. Antipsikotik ilaçların kardiyovasküler yan etkileri. Psikiyatride Güncel Yaklaşımlar Derg 2011;13:157–252
  4. Polcwiartek C, Kragholm K, Schjerning O, Graff C, Nielsen J. Cardiovascular safety of antipsychotics: a clinical overview. Expert Opin Drug Saf 2016;15:679–688. [CrossRef] 11. Mouaffak F, Gaillard R, Burgess E, Zaki H, Olié JP, Krebs MO. Clozapineinduced serositis: review of its clinical features, pathophysiology and management strategies. Clin Neuropharmacol 2009;32:219–223. [CrossRef] 12. Şahpolat M, Küçükdurmaz Z, Kavakçı Ö, Kurt R. Paliperidone: As a Possible Cause of Pericardial Effusion. Noro Psikiyatr Ars 2014;51:169–171. [CrossRef] 13. Alagha K, Tummino C, Sofalvi T, Chanez P. Iatrogenic eosinophilic pleural effusion. Eur Respir Rev 2011;20:118–120. [CrossRef] 14. Schatzberg AF, Nemeroff CB. The Textbook of Psychopharmacology, 4th ed. American Psychiatric Publishing 2009. pp.573–599
  5. Elman I, Goldstein DS, Eisenhofer G, Folio J, Malhotra AK, Adler CM, Pickar D, Breier A. Mechanism of peripheral noradrenergic stimulation by clozapine. Neuropsychopharmacol 1